Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa
Authors:
Open Access
- 22 October 2015
- journal article
- research article
- Published by Springer Nature in Parasites & Vectors
- Vol. 8 (1) , 1-14
Abstract
Effective control of schistosomiasis remains a challenging problem for endemic areas of the world. Given knowledge of the biology of transmission and past experience with mass drug administration (MDA) programs, it is important to critically evaluate the likelihood that MDA programs will achieve substantial reductions in Schistosoma prevalence. In implementing the World Health Organization Roadmap for Neglected Tropical Diseases it would useful for policymaking to model projections of the status of Schistosoma control in MDA-treated areas in the next 5–10 years. Calibrated mathematical models were used to project the effects of different frequency and coverage of MDA for schistosomiasis haematobia control in present-day endemic communities, taking into account uncertainties of parasite biology and input data. The modeling approach in this analysis was the Stratified Worm Burden model developed in our earlier works, calibrated using data from longitudinal S. haematobium control trials in Kenya. Model-based simulations of MDA control in typical low-risk and higher-risk communities indicated that infection prevalence can be substantially reduced within 10 years only when there is a high degree of community participation (>70 %) with at least annual MDA. Significant risk for re-emergence of infection remains if MDA is suspended. In a stable (stationary) ecosystem, Schistosoma reproduction and transmission are sufficiently robust that the process of human infection continues, even under pressure from aggressive MDA. MDA alone is unlikely to interrupt transmission, and once mass treatment is suspended, the prevalence of human infection is likely to rebound to pre-control levels over a period of 25–30 years. MDA success in achieving very low levels of infection prevalence is highly dependent on treatment coverage and frequency within the local human population, and requires that both adults and children be included in drug delivery coverage. Ultimately, supplemental snail control and significant improvements in sanitation will be required to achieve full control of schistosomiasis by elimination of ongoing Schistosoma transmission.Keywords
Funding Information
- Childrens Investment Fund Foundation (ᅟ)
This publication has 40 references indexed in Scilit:
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Projecting the Long-Term Impact of School- or Community-Based Mass-Treatment Interventions for Control of Schistosoma InfectionPLOS Neglected Tropical Diseases, 2012
- Evaluation of a 25-Year-Program for the Control of Schistosomiasis Mansoni in an Endemic Area in BrazilPLOS Neglected Tropical Diseases, 2011
- A new approach to modelling schistosomiasis transmission based on stratified worm burdenParasitology, 2010
- Schistosoma japonicum Reinfection after Praziquantel Treatment Causes Anemia Associated with InflammationInfection and Immunity, 2006
- Estimating the distribution of worm burden and egg excretion of Schistosoma japonicum by risk group in Sichuan Province, ChinaParasitology, 2002
- Worm burdens in schistosome infectionsParasitology Today, 1996
- Underestimation of Schistosoma mansoni prevalencesParasitology Today, 1992
- A model for variations in single and repeated egg counts in schistosoma mansoni infectionsParasitology, 1992
- Togetherness among Schistosomes: its effects on the dynamics of the infectionMathematical Biosciences, 1977